A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials ; volume:23 ; number:1 ; day:2 ; month:3 ; year:2023 ; pages:1-12 ; date:12.2023
BMC medical research methodology ; 23, Heft 1 (2.3.2023), 1-12, 12.2023
- Creator
-
Li, Zhaohang
Xu, Ze
Zhang, Aijun
Qi, Guanpeng
Li, Zuojing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12874-023-01867-y
- URN
-
urn:nbn:de:101:1-2023121408482206696665
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Zhaohang
- Xu, Ze
- Zhang, Aijun
- Qi, Guanpeng
- Li, Zuojing
- SpringerLink (Online service)
Other Objects (12)
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
Optimal dose‐finding for efficacy–safety models
Response-adaptive dose-finding under model uncertainty
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine
Dose-finding studies in drug development for rare genetic diseases
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
A multiple comparison procedure for dose‐finding trials with subpopulations
Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study
Implementing the EffTox dose-finding design in the Matchpoint trial
Oral mannitol for bowel preparation: a dose-finding phase II study
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
Optimal dose‐finding for efficacy–safety models
Response-adaptive dose-finding under model uncertainty
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine
Dose-finding studies in drug development for rare genetic diseases
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
A multiple comparison procedure for dose‐finding trials with subpopulations
Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study
Implementing the EffTox dose-finding design in the Matchpoint trial
Oral mannitol for bowel preparation: a dose-finding phase II study
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
Optimal dose‐finding for efficacy–safety models
Response-adaptive dose-finding under model uncertainty
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine
Dose-finding studies in drug development for rare genetic diseases
Stereotactic body radiotherapy of adrenal metastases - a dose‐finding study
A multiple comparison procedure for dose‐finding trials with subpopulations
Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study
Implementing the EffTox dose-finding design in the Matchpoint trial